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SUPPLEMENTARY INFORMATION 
Initial development of a cytotoxic amino-seco-CBI warhead for delivery by prodrug 
systems 
Elvis A. Twum, Amit Nathubhai, Pauline J. Wood, Matthew D. Lloyd, Andrew S. Thompson 
and Michael D. Threadgill*
 
Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, 
Claverton Down, Bath BA2 7AY, UK 
Synthetic methods for 31-33,37 
Naphthalene-1,4-dione (14). KNO3 (35.5 mg, 0.35 mmol) was added to 13 (67.6 mg, 0.35 
mmol) in CF3CO2H (10 mL) at -20°C. The mixture was stirred at -20°C for 35 min and 
poured onto ice. Extraction (EtOAc), drying and chromatography (CH2Cl2 / EtOAc 3:2) gave 
14 (41.4 mg, 75%) as a pale buff solid: mp 124-126C (lit.1 125-127°C); 1H NMR 
((CD3)2SO) (COSY)  7.14 (2 H, s, 2,3-H2), 7.93 (2 H, m, 6,7-H2), 8.04 (2 H, m, 5,8-H2); 
13
C 
NMR ((CD3)2SO)  125.83 (5,8-C2), 131.53 (4a,8a-C2), 134.18 (6,7-C2), 138.70 (2,3-C2), 
184.80 (1,4-C2); MS m/z 159.0446 (M + H)
+
 (C10H7O2 requires 159.0446). 
4-Amino-2-nitronaphthalen-1-ol (16). SnCl2.2H2O (15.0 g, 67 mmol) in EtOH (20 mL) was 
added to 15 (5.04 g, 22 mmol) in aq. HCl (9 M, 20 mL) and EtOH (10 mL) during 1 h at < 
35C. The mixture was stirred for 17 h at 20C. The suspension was filtered and the solid was 
washed with EtOH / aq. HCl (9 M) (3:2). The yellow solid was partitioned between EtOAc 
and water. The aqueous layer was extracted (EtOAc, 3). The combined extracts were washed 
(brine) and dried. Evaporation and chromatography (CH2Cl2) gave 16 (3.11 g, 71%) as a pale 
pink solid: mp 160-161C (lit.2 mp 160C); IR νmax 3418, 3337 cm
-1
; 
1
H NMR  3.98 (2 H, s, 
NH2), 7.26 (1 H, s, 3-H), 7.64 (1 H, dd, J = 8.1, 7.0 Hz, 7-H), 7.74 (1 H, dd, J = 8.3, 6.9 Hz, 
6-H), 7.83 (1 H, d, J = 8.4 Hz, 5-H), 8.53 (1 H, dd, J = 8.3, 0.6 Hz, 8-H), 11.92 (1 H, s, OH);
 
13
C NMR  100.54 (3-C), 121.42 (5-C), 125.65 (8a-C), 125.92 (8-C), 127.15 (7-C), 127.90 
(2-C), 129.56 (4a-C), 130.87 (6-C), 135.18 (4-C), 150.11 (1-C); MS m/z 203.0466 (M - H)
-
 
(C10H7N2O3 requires 203.0457). 
4-Amino-2-nitronaphthalen-1-yl 1,1-dimethylethyl carbonate (17). Compound 16 (54 mg, 
0.26 mmol) was stirred with Boc2O (60 mg, 0.28 mmol) and 4-dimethylaminopyridine (25 
mg, 0.20 mmol) in CH2Cl2 (17 mL) for 30 min under N2. The mixture was washed (water, 
brine) and dried. Evaporation and chromatography (CH2Cl2) gave 17 (14 mg, 17%) as a 
yellow solid, which decomposed on heating: 
1
H NMR  1.60 (9 H, s, But), 4.34 (2 H, s, NH2), 
7.29 (1 H, s, 3-H), 7.62-7.66 (2 H, m, 6,7-H2), 7.81 (1 H, m, 5-H), 8.15 (1 H, m, 8-H); 
13
C 
NMR  27.60 (CMe3), 84.87 (CMe3), 102.48 (3-C), 121.22 (5-C), 124.15 (8-C), 126.12 (4a-
C), 128.14 (6-C), 128.20 (8a-C), 128.67 (7-C), 133.79 (4-C), 137.91 (2-C), 141.07 (1-C), 
150.94 (C=O). 
1,1-Dimethylethyl (4-hydroxy-3-nitronaphthalen-1-yl)carbamate (18). Compound 16 (560 
mg, 2.7 mmol) was stirred with Boc2O (3.04 g, 14 mmol) in dry THF (25 mL) under N2 under 
reflux for 20 h. The mixture was cooled. The evaporation residue, in CH2Cl2, was washed 
(water, brine). Drying, evaporation and chromatography (petroleum ether / EtOAc 9:1) gave 
18 (740 mg, 89%) as an orange solid: mp 175-177ºC; IR νmax 3338, 3259, 1687, 1525 cm
-1
; 
1
H 
NMR (NOESY)  1.55 (9 H, s, But), 6.59 (1 H, br s, NH), 7.65 (1 H, ddd, J = 8.2, 7.0, 1.1 Hz, 
6-H), 7.77 (1 H, ddd, J = 8.2, 6.9, 1.2 Hz, 7-H), 7.87 (1 H, d, J = 8.4 Hz, 8-H), 8.33 (1 H, s, 2-
H), 8.56 (1 H, dd, J = 8.4, 0.5 Hz, 5-H), 12.11 (1 H, s, OH);
 13
C NMR  28.31 (CMe3), 81.31 
(CMe3), 112.82 (2-C), 121.46 (8-C), 125.45 (8a-C), 125.83 (4-C), 125.91 (4a-C), 127.25 (6-
C), 127.55 (3-C), 131.56 (7-C), 152.98 (4-C), 153.50 (C=O); MS m/z 327.0966 (M + Na)
+
 
(C15H16N2NaO5 requires 327.0957). 
4-(1,1-Dimethylethoxycarbonylamino)-2-nitronaphthalen-1-yl 
trifluoromethanesulfonate (19). (F3CSO2)2O (1.20 g, 4.2 mmol) was added dropwise during 
45 min to 18 (808 mg, 2.7 mmol) in dry pyridine (20 mL) under N2 at 0C and the mixture 
was stirred for 30 min at 0C. The mixture was then warmed to 20C during 10 min. Water 
was added and the mixture was extracted (EtOAc). Drying, evaporation and chromatography 
(CH2Cl2 → CH2Cl2 / EtOAc 1:1 → EtOAc) gave 19 (942 mg, 81%) as a yellow solid: mp 
110-111°C; IR νmax 3435, 1737 cm
-1
; 
1
H NMR (NOESY)  1.59 (9 H, s, But), 7.19 (1 H, s, 
NH), 7.78-7.82 (2 H, m, 6,7-H2), 7.96 (1 H, d, J = 8.0 Hz, 5-H), 8.29 (1 H, d, J = 8.2 8-H), 
8.73 (1 H, s, 3-H); 
13
C NMR  28.20 (CMe3), 82.54 (CMe3), 110.52 (3-C), 118.42 (q, J = 
321.2 Hz, CF3), 121.34 (5-C), 125.19 (8-C), 127.13 (8a-C), 127.51 (4a-C), 129.35 (6-C or 7-
C), 130.12 (7-C or 6-C), 132.72 (2-C), 134.61 (4-C), 143.02 (1-C), 152.20 (C=O).
 19
F NMR 
(CDCl3)  -72.55 (s, CF3); MS m/z 459.0484 (M + Na)
+
 (C16H15F3N2NaO7S requires 
459.0450).  
1,1-Dimethylethyl N-(3-amino-4-oxonaphthalen-1-ylidene)carbamate (21). Compound 18 
(66 mg, 0.22 mmol) was stirred vigorously with Pd/C (36.5 mg) in MeOH (20 mL) under H2 
for 1.5 h. Filtration (Celite
®
) and evaporation gave 21 (51 mg, 84%) as a dark buff solid: mp 
155-156°C; IR νmax 3331, 1704 cm
-1
; 
1
H NMR  1.61 (9 H, s, But), 5.06 (2 H, s, NH2), 6.10 (1 
H, s, 2-H), 7.58 (1 H, t, J = 7.2 Hz, 6-H), 7.65 (1 H, t, J = 6.9 Hz, 7-H), 8.09 (1 H, d, J = 7.6 
Hz, 5-H), 8.29 (1 H, d, J = 7.7 Hz, 8-H); 
13
C NMR  28.23 (CMe3), 82.26 (CMe3), 99.01 (2-
C), 125.78 (8-C), 126.33 (5-C), 130.41 (4a-C), 131.27 (6-C), 133.62 (7-C), 134.84 (8a-C), 
144.84 (3-C), 157.13 (1-C), 162.94 (Boc C=O), 180.70 (4-C); MS m/z 567.2262 (2 M + Na)
+
 
(C30H32N4NaO6 requires 567.2220), 295.1052 (M + Na)
+
 (C15H16N2NaO3 requires 295.1059). 
1,1-Dimethylethyl N-(4-oxo-3-(2,2,2-trifluoroacetamido)naphthalen-1-ylidene)carbamate 
(22). K2CO3 (178 mg, 1.3 mmol) and Na2S2O4 (198 mg, 1.1 mmol) in water (4.0 mL) were 
added dropwise to 18 (75 mg, 0.25 mmol) in CH2Cl2 (8.0 mL) and water (1.0 mL) under N2. 
Stirring was continued for 16 h at 35°C. The organic phase was separated, dried and filtered. 
The filtrate was cooled to 0°C. Pr
i
2NEt (580 mg, 4.5 mmol) was added, followed by dropwise 
addition of (F3CCO)2O (315 mg, 1.5 mmol). The mixture was stirred at 0C for 15 min then at 
20C for 2 h, before being washed with (water, brine) and dried. Evaporation and chromato-
graphy (petroleum ether / EtOAc 9:1) gave 22 (39 mg, 42%) as a yellow solid: mp 122-
123°C; IR νmax 3290, 3097, 1744 cm
-1
; 
1
H NMR  1.66 (9 H, s, But), 7.71 (1 H, ddd, J = 9.0, 
7.7, 1.9 Hz, 6-H), 7.78 (1 H, ddd, J = 8.9, 7.4, 1.5 Hz, 7-H), 8.13 (1 H, s, 2-H), 8.19 (1 H, dd, 
J = 7.7, 1.1, Hz, 5-H), 8.36 (1 H, dd, J = 7.8, 0.9 Hz, 8-H), 9.17 (1 H, s, NH); 
13
C NMR  
28.13 (CMe3), 84.22 (CMe3), 114.57 (2-C), 114.72 (q, J = 288.4 Hz, CF3), 126.11 (8-C), 
127.12 (5-C), 129.40 (4a-C), 132.45 (6-C), 133.67 (3-C), 134.80 (7-C), 135.00 (8a-C), 155.28 
(Boc C=O), 155.57 (q, J = 39.2 Hz, CF3C=O), 161.36 (1-C), 178.63 (4-C); 
19
F NMR 
(CDCl3)-75.76 (s, CF3); MS m/z 367.0941 (M - H)
-
 (C17H14F3N2O4 requires 367.0906). 
Ethyl 5-hydroxyindole-2-carboxylate (31). 5-Hydroxyindole-2-carboxylic acid 30 (1.53 g, 
8.6 mmol) was boiled under reflux in EtOH (100 mL) saturated with HCl under N2 for 4 h. 
The evaporation residue, EtOAc, was washed (water, brine). Drying, evaporation and 
chromatography (CH2Cl2 → CH2Cl2 / EtOAc 4:1) gave 31 (1.64 g, 92%) as a white solid: mp 
152-154°C (lit.
3
 146-148°C); IR νmax 3316, 3209, 1696 cm
-1
; 
1
H NMR ((CD3)2SO)  1.38 (3 
H, t, J = 7.1 Hz, Me), 4.37 (2 H, q, J = 7.1 Hz, CH2), 6.86 (1 H, dd, J = 8.8, 2.4 Hz, 6-H), 6.97 
(1 H, d, J = 2.3 Hz, 4-H), 7.00 (1 H, dd, J = 2.1, 0.8 Hz, 3-H), 7.32 (1 H, d, J = 8.8 Hz, 7-H), 
8.93 (1 H, s, OH), 11.60 (1 H, s, NH). 
13
C NMR ((CD3)2SO)  14.29 (Me), 60.17 (CH2), 
104.43 (4-C), 106.66 (3-C), 113.07 (7-C), 116.15 (6-C),  127.36 (2-C or 3a-C), 127.44 (3a-C 
or 2-C), 132.21 (7a-C), 151.34 (5-C), 161.30 (C=O).  
Ethyl 5-(2-Dimethylaminoethoxy)indole-2-carboxylate (32). Me2N(CH2)2Cl.HCl (1.77 g, 
12 mmol), K2CO3 (3.40 g, 25 mmol) and water (8 mL) were added to 31 (1.68 g, 8.2 mmol) 
in CHCl3 (40 mL). The stirred solution was placed in an oil bath at 65°C. The temperature 
was slowly raised to 80°C during 65 min and the mixture was stirred for 16 h at 80C. The 
organic phase was separated and the solvent was evaporated to 25% of its original volume. 
This solution was combined with the aqueous phase and diluted with water and toluene. The 
organic layer was separated, washed with water and extracted with aq. HCl (1.0 M). The 
acidic phase was washed (toluene), cooled to 0°C, basified (~pH 12) by addition of aq. NaOH 
(4.0 M) and extracted (toluene). The extract was washed (water, brine) and dried. Evaporation 
gave 32 (1.81 g, 80%) as a white solid: mp 108-109 (lit.
3
 mp 110°C); IR νmax 3315, 1687; 
1
H 
NMR  1.39 (3 H, t, J = 7.1 Hz, OCH2CH3), 2.35 (6 H, s, NMe2), 2.76 (2 H, t, J = 5.8 Hz, 
Me2NCH2CH2), 4.10 (2 H, t, J = 5.8 Hz, Me2NCH2CH2), 4.39 (2 H, q, J = 7.1 Hz, 
OCH2CH3), 6.99 (1 H, dd, J = 8.9, 2.4 Hz, 6-H), 7.07 (1 H, d, J = 2.4 Hz, 4-H), 7.12 (1 H, dd, 
J = 2.1, 0.8 Hz, 3-H), 7.28 (1 H, d, J = 8.9 Hz, 7-H), 9.30 (1 H, s, NH); 
13
C NMR  14.32 
(OCH2CH3), 45.83 (NMe2), 58.38 (Me2NCH2CH2), 60.82 (OCH2CH3), 66.57 
(Me2NCH2CH2), 103.67 (4-C), 108.13 (3-C), 112.69 (7-C), 117.37 (6-C), 127.74 (2-C), 
127.89 (3a-C), 132.42 (7a-C), 153.83 (5-C), 162.01 (C=O).  
Ethyl 5-(2-Dimethylaminoethoxy)indole-2-carboxylate (33). Ester 32 (609 mg, 2.2 mmol) 
was heated with Cs2CO3 (2.50 g, 7.7 mmol) in MeOH (12 mL) and water (6 mL) at reflux for 
2 h. The evaporation residue, in water, was adjusted to pH 6.5 with aq. HCl (1.0 M). The 
mixture was cooled to 4C for 18 h. The crystals were collected by filtration, washed (ice-
cold water, acetone) to give 33 (419 mg, 77%) as white crystals. A sample of the product was 
treated with HCl in 1,4-dioxane (4.0 M) and EtOAc. Filtration gave 33.HCl as a white solid: 
mp 238-239C (lit.4 mp 237-239C); IR νmax 3380, 3240, 1593 cm
-1
; 
1
H NMR ((CD3)2SO)  
2.37 (6 H, s, NMe2), 2.81 (2 H, t, J = 5.7 Hz, NCH2), 4.12 (2 H, t, J = 5.8 Hz, OCH2), 6.91 (1 
H, dd, J = 8.9, 2.4 Hz, 6-H), 6.95 (1 H, d, J = 1.5 Hz, 3-H), 7.14 (1 H, d, J = 2.3 Hz, 4-H), 
7.35 (1 H, d, J = 8.9 Hz, 7-H), 11.50 (1 H, s, NH);
 13
C NMR ((CD3)2SO)  45.04 (NMe2), 
57.39 NCH2), 65.66 OCH2), 103.18 (4-C), 106.06 (3-C), 113.21 (7-C), 115.50 (6-C), 127.27 
(3a-C), 130.33 (2-C), 132.39 (7a-C), 152.69 (5-C), 163.30 (C=O).  
S-Oxiran-2-ylmethyl 4-nitrobenzenesulfonate (37). 4-Nitrobenzenesulfonyl chloride (3.16 
g, 14 mmol) was added portionwise to Et3N (2.3 mL, 1.67 g, 16 mmol) and R-oxiranylmeth-
anol 36 (1.00 g, 14 mmol) in toluene at 0°C. The mixture was stirred at 20C for 30 min. The 
suspension was filtered (Celite
®
). The evaporation residue, in CH2Cl2, was washed (aq. 
H2SO4 (2%), sat. aq. NaHCO3, brine). Drying, evaporation and recrystallisation (toluene / 
hexane) gave 37 (1.69 g, 40%) as a white solid: mp 82-83ºC (lit.
5
 mp 84-86°C); []18D (c = 
6.5, CHCl3) + 33.3º (lit.
6
 [25D + 26.5° (c 2.45, CHCl3, 82% e.e.)); 
1
H NMR  2.60 (1 H, dd, 
J = 4.7, 2.5 Hz, 3-H), 2.83 (1 H, t, J = 4.4 Hz, 3-H), 3.20 (1 H, m, 2-H), 4.02 (1 H, dd, J = 
11.6, 6.4 Hz, SOCH), 4.46 (1 H, dd, J = 11.6, 2.9 Hz, SOCH), 8.12 (2 H, m, Ph 2,6-H2), 8.40 
(2 H, m, Ph 3,5-H2); 
13
C NMR (CDCl3)  44.42 (3-C), 48.61 (2-C), 71.62 (SOCH2), 124.43 
(Ph 3,5-C2), 129.24 (Ph 2,6-C2), 141.59 (Ph 1-C), 150.84 (Ph 4-C). 
1,1-Dimethylethyl N-(R-1-iodo-2-(N-(oxiranylmethyl)-2,2,2-trifluoroacetamido)naphth-
alen-4-yl)carbamate (diastereomeric atropisomers 38A & 38B). Compound 29 (21 mg, 43 
µmol) was stirred with 37 (17 mg, 66 µmol) and K2CO3 (26 mg, 0.19 mmol) in acetone (20 
mL) at 50C under N2 for 3 d. Sat. aq. NaHCO3 was added to the mixture, which was 
extracted with EtOAc. The extract was washed (brine) and dried. Evaporation and chromato-
graphy (petroleum ether / EtOAc 19:1  9:1) gave 38A (7.8 mg, 34%) as a yellow oil: 1H 
NMR (NOESY)  1.56 (5.4 H, s, But rotamer a), 1.56 (3.6 H, s, But rotamer b), 2.45 (0.4 H, 
dd, J = 4.6, 2.4 Hz, oxirane 3-C rotamer b), 2.56 (0.6 H, dd, J = 4.8, 2.5 Hz, oxirane 3-H 
rotamer a), 2.84 (1 H, m, oxirane 3-H rotamers a,b), 3.17 (0.6 H, dd, J = 14.3, 7.1 Hz, 
CHNCOCF3 rotamer a), 3.34 (0.4 H, m, oxirane 2-H rotamer b), 3.38 (0.4 H, dd, J = 13.6, 5.8 
Hz, CHNCOCF3 rotamer b), 3.44 (0.6 H, m, oxirane 2-H rotamer a), 4.55 (0.4 H, dd, J = 
13.8, 4.6 Hz, CHNCOCF3 rotamer b), 4.63 (0.6 H, dd, J = 14.3, 3.9 Hz, CHNCOCF3 rotamer 
a), 6.99 (1 H, s, NH rotamers a,b), 7.63-7.67 (2 H, m, 6,7-H2 rotamers a,b), 7.86 (1 H, m, 5-H 
rotamers a,b), 8.06 (0.4 H, s, 3-H rotamer b), 8.18 (0.6 H, s, 3-H rotamer a), 8.31 (1 H, m, 8-
H rotamers a,b);
 13
C NMR  28.30 (CMe3 rotamer b), 28.33 (CMe3 rotamer a), 45.67 (oxirane 
3-C rotamer a), 46.70 (oxirane 3-C rotamer b), 48.02 (oxirane 2-C rotamer b), 49.31 (oxirane 
2-C rotamer a), 53.29 (CH2NCOCF3 rotamer b), 54.66 (CH2NCOCF3 rotamer a), 81.64 
(CMe3 rotamer a), 81.68 (CMe3 rotamer b), 99.03 (1-C rotamer a), 99.45 (1-C rotamer b), 
115.88 (q, J = 288.4 Hz, CF3 rotamers a,b), 118.47 (3-C rotamers a,b), 120.55 (5-C rotamer 
b), 120.59 (5-C rotamer a), 125.80 (4a-C rotamers a,b), 128.05 (6-C rotamer a), 128.13 (6-C 
rotamer b), 128.78 (7-C rotamer a), 128.86 (7-C rotamer b), 134.42 (8-C rotamer a), 134.55 
(8-C rotamer b), 135.06 (8a-C rotamer a), 135.09 (4-C rotamers a,b), 135.11 (8a-C rotamer 
b), 140.32 (2-C rotamer b), 140.80 (2-C rotamer a), 152.43 (Boc C=O rotamers a,b), 157.09 
(q, J = 36.5 Hz, F3CC=O rotamer a), 157.20 (q, J = 38.1 Hz, F3CC=O rotamer b); 
19
F NMR  
-68.40 (0.4 F, s, CF3 rotamer b), -68.52 (0.6 F, s, CF3 rotamer a); MS m/z 537.0504 (M + H)
+
 
(C20H21F3IN2O4 requires 537.0498). Further elution gave 38B (9.1 mg, 39%) as a pale yellow 
oil:
1
H NMR (NOESY)  1.55 (9 H, s, But), 2.78 (1 H, dd, J = 4.7, 2.6 Hz, oxirane 3-H), 2.95 
(1 H, t, J = 4.5 Hz, oxirane 3-H), 3.49 (1 H, m, oxirane 2-H), 4.30 (1 H, dd, J = 12.2, 6.2 Hz, 
CHNCOCF3), 4.71 (1 H, dd, J = 12.2, 2.8 Hz, CHNCOCF3), 6.70 (1 H, s, NH), 7.47 (1 H, t, J 
= 7.7 Hz, 6-H), 7.57 (1 H, m, 7-H), 7.63 (1 H, s, 3-H), 7.76 (1 H, d, J = 8.4 Hz, 5-H), 8.19 (1 
H, d, J = 8.5 Hz, 8-H);
 13
C NMR  28.29 (CMe3), 44.85 (oxirane 3-C), 48.89 (oxirane 2-C), 
69.29 (CH2NCOCF3), 81.25 (CMe3), 85.75 (1-C), 110.89 (3-C), 115.72 (q, J = 284.6 Hz, 
CF3), 120.33 (5-C), 123.42 (4a-C), 125.48 (6-C), 128.25 (7-C), 132.53 (8-C), 134.43 (4-C), 
134.95 (8a-C), 145.08 (2-C), 152.71 (C=O Boc); 
19F NMR δ -75.62 (s, CF3); MS m/z 
537.0504 (M + H)
+
 (C20H21F3IN2O4 requires 537.0498). 
1,1-Dimethylethyl S-N-(1-iodo-2-(oxiran-2-ylmethylamino)naphthalen-4-yl)carbamate 
(40). MeLi in Et2O (1.6 M, 0.24 mL, 0.39 mmol) was added dropwise (~5 min) to a stirred 
suspension of CuCN (17.4 mg, 0.19 mmol) in dry THF (0.6 mL) at -78C under N2 and the 
mixture was stirred for 5 min. The mixture was brought to 40C and stirred for 30 min. After 
being cooled to -78C, compound 38 (65.6 mg, 0.12 mmol) in dry THF (0.6 mL) was added 
dropwise and stirring was continued at -78C. The mixture was stirred at 25C for 3 d. Water 
was added. The mixture was extracted (EtOAc). The extract was washed (brine). Drying, 
evaporation and chromatography (petroleum ether / EtOAc 9:1) gave 40 (39 mg, 73%) as a 
yellow solid: mp 127-128°C; IR νmax 3389, 3336, 3082, 1699 cm
-1
; 
1
H NMR (NOESY)  1.56 
(9 H, s, Bu
t
 conformers A,B), 2.77 (0.45 H, d, J = 2.6 Hz, oxirane 3-H conformer B), 2.78 
(0.55 H, d, J = 2.7 Hz, oxirane 3-H conformer A), 2.84 (0.45 H, d, J = 2.6 Hz, oxirane 3-H 
conformer B), 2.86 (1 H, d, J = 4.0 Hz, oxirane 3-H conformer A), 3.27 (1 H, m, oxirane 2-H 
conformers A,B), 3.51 (0.55 H, dd, J = 6.2, 4.6 Hz, NCHH conformer A), 3.55 (0.45 H, dd, J 
= 6.2, 4.6 Hz, NHCHH conformer B), 3.71 (0.45 H, dd, J = 5.7, 3.5 Hz, NHCHH conformer 
B), 3.75 (0.55 H, dd, J = 5.7, 3.5 Hz, NCHH conformer A), 4.87 (1 H, t, J = 5.8 Hz, NHCH2 
conformers A,B), 6.93 (1 H, s, Boc NH conformers A,B), 7.26 (1 H, ddd, J = 8.1, 6.8, 1.1 Hz, 
6-H conformers A,B), 7.45 (1 H, ddd, J = 8.1, 6.8, 1.2 Hz, 7-H conformers A,B), 7.62 (1 H, d, 
J = 8.2 Hz, 5-H conformers A,B), 7.74 (1 H, s, 3-H conformers A,B), 7.99 (1 H, dd, J = 8.6, 
0.6 Hz, 8-H conformers A,B); 
13
C NMR  28.32 (CMe3), 45.38 (NCH2), 45.44 (oxirane 3-C), 
50.82 (oxirane 2-C), 78.88 (1-C), 80.91 (CMe3), 105.08 (3-C), 120.13 (5-C), 120.74 (4a-C), 
122.63 (6-C), 128.10 (7-C rotamer a), 131.02 (8-C), 135.03 (4-C), 135.59 (8a-C), 145.84 (2-
C), 152.84 (C=O); MS m/z 463.0522 (M + Na)
+
 (C18H21IN2NaO3 requires 463.0495). 
1,1-Dimethylethyl N-(1-iodo-2-(N-(prop-2-enyl)-2,2,2-trifluoroacetamido)naphthalene-4-
yl)-N-(prop-2-enyl)carbamate (41). Compound 29 (99.4 mg, 0.21 mmol), K2CO3 (119 mg, 
0.83 mmol) and 3-bromopropene (84 mg, 0.69 mmol) in acetone (15 mL) were stirred at 50°C 
under N2 for 16 h. Sat. aq. NaHCO3 was added and mixture was extracted (EtOAc). Washing 
(brine), drying and evaporation gave 41 (115 mg, 99%) as a yellow oil: IR νmax 1698 cm
-1
; 
1
H 
NMR (COSY)  1.23 (0.6 H, br, But conformers A,B), 3.71 (0.6 H, dd, J = 14.4, 8.3 Hz, 
CF3CONCH conformer A), 3.76 (0.4 H, dd, J = 14.4, 8.0 Hz, CF3CONCH conformer B), 3.83 
(0.6 H, dd, J = 14.9, 7.4 Hz, BocNCH conformer A), 3.95 (0.4 H, dd, J = 14.7, 7.1 Hz, 
BocNCH conformer B), 4.53 (0.4 H, m, BocNCH conformer B), 4.64 (0.6 H, m, BocNCH 
conformer A), 4.98-5.21 (5 H, m, 2 × propenyl 3-H, CF3CONCH conformers A,B), 5.85-5.94 
(2 H, m, 2 × propenyl 2-H conformers A,B), 7.11 (1 H, s, 3-H conformers A,B), 7.61-7.68 (2 
H, m, 6,7-H2 conformers A,B), 7.83 (1 H, m, 5-H conformers A,B), 8.31 (1 H, m, 8-H confor-
mers A,B);
 13
C NMR  27.88 (CMe3 conformer A), 28.11 (CMe3 conformer B), 52.45 
(BocNCH2 conformers A,B), 53.69 (CF3CONCH2 conformer A), 80.78 (CMe3 conformers 
A,B), 105.48 (1-C conformers A,B), 115.94 (q, J = 289.4 Hz, CF3 conformers A,B), 118.46 
(BocNCH2CHCH2 conformers A,B), 120.92 (CF3CONCH2CHCH2 conformers A,B), 123.42 
(5-C conformer B), 123.57 (5-C conformer A), 127.79 (3-C conformer B), 128.11 (3-C 
conformer A), 128.52 (6-C or 7-C conformers A,B), 128.91 (7-C or 6-C conformers A,B), 
130.31 (CF3CONCH2CHCH2 conformers A,B), 130.99 (4a-C conformers A,B), 133.37 
(BocNCH2CHCH2 conformers A,B), 133.87 (8-C conformers A,B), 135.71 (8a-C conformers 
A,B), 139.39 (2-C conformers A,B), 139.86 (4-C conformers A,B), 154.53 (Boc C=O 
conformers A,B), 156.42 (q, J = 36.0 Hz, CF3C=O conformer B); 156.50 (q, J = 35.0 Hz, 
CF3C=O conformer A); 
19F NMR δ -68.58 (1.2 F, s, CF3 conformer B), -68.65 (1.8 F, s, CF3 
conformer A); MS m/z 583.0804 (M + Na)
+
 (C23H24F3IN2NaO3 requires 583.0681).  
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